Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move
across top level links and expand / close menus in sub levels. Up and Down arrows will open main level
menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab
will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Join the brightest minds in regulatory at the annual Regulatory Convergence. See the global regulatory community in action. Intensive workshops. Topical sessions. Meet ups with regulators. This is where it all comes together.
For 20 years, our flagship publication, Fundamentals of US Regulatory Affairs, has been giving regulatory professionals the insights and answers they need, right at their fingertips.
There are hundreds of RAC testing centers available worldwide. Any of the four RAC exams (US, EU, CAN or Global) may be taken at any location. Find an upcoming exam at a location near you.
Posted 01 June 2012 | By Alexander Gaffney, RAC
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) is announcing the launch of new guidance to assist sponsors looking to comply with the terms of new regulations set to change how sponsors can label their products.
Under the terms of the Better Regulation of Medicines Initiative (BROMI), MHRA is taking a more targeted approach to how it regulates medicines by re-focusing its resources on higher-risk activities.
One of the numerous changes to be implemented under the re-organization is a reformed notification scheme for registering amendments to labeling and patient information leaflets, which is scheduled to come into effect in July 2012. To help sponsors prepare for the new regulations, MHRA said it is releasing guidance to industry two months in advance of the changes to allow them to understand the regulations.
The guidance documents include information on the best practices for labeling and packaging medicines, additional warning statements to be included on the packaging or package inserts of certain medicines, how to submit packaging or patient leaflets to MHRA for assessment, how to make changes to leaflets or package inserts and best practices for patient information leaflets.
MHRA is also announcing a series of three workshops to help train industry on the changes. The workshops will occur in June and will be hosted by the British Generics Manufacturers' Association.
MHRA - New BROMI Notification Scheme guidance
Tags: PILs, Patient Information Leaflets, BROMI, Latest News, UK, guidance, regulations
Regulatory Focus newsletters
All the biggest regulatory news and happenings.